Effect of hemofiltration combined with hemoperfusionon serum TNF-« in severe acute pancreatitis patients with lung injury and on RhoA serine 188 phosphorylation in endotheliai cells
10.3724/SP.J.1008.2013.00738
- Author:
Qian ZHENG
1
Author Information
1. Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University
- Publication Type:Journal Article
- Keywords:
Endothelial cells;
Hemofiltration;
Hemoperfusion;
Lung injuries;
RhoA;
Severe acute pancreatitis;
Tumor necrosis factor-alpha
- From:
Academic Journal of Second Military Medical University
2013;34(7):738-744
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of hemofiltration plus hemoperfusion (HF+HP) on removal of serum TNF-a in severe acute pancreatitis (SAP) patientswith lung injury and on RhoA serine 188 phosphorylation (p-RhoA) in endothelial cells. Methods Totally 35 SAP patients, including 28 with acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS), and 20 healthy subjectswere involved in this study. All the SAP patients were treated in ICU, and the 9 combined with ARDS underwent continuous veno-venous hemofiltration (CVVH) and HP therapy (HF+HP group). The serum TNF-a in SAP patients with different degrees of lung injury and the serum TNF-« in SAP patients with ARDS was determined by ELISA at different time points during HF+HP. For in vitro study the human umbilical vein endothelial cells (HUVECs) were treated with sera from SAP patientswith ARDS during HF+HP, and those treated with recombinant TNF-a were taken as a positive control. The changes of p-RhoA and total RhoA were observed by Western blotting analysis. Subcellular distribution of p-RhoA protein was observed by immunofluorescence staining. Results We found that, compared withSAP patients without ALI/ARDS, those with ALI/ARDS, especially those with ARDS (about 7 folds that of the normal control) had a significantly increased serum TNF-« level (P<0. 05). The serum TNF-« level began to decrease in the 9 SAP patients with ARDS 6 h after HF+HP treatment, with the decrease reached maximal 20 h after treatment, closing to the level of the normal control group. Meanwhile, the arterial blood Pa02, HCO3 _ and Pa02/Fi02 ratio were significantly elevated after HF+HP treatment in SAP patients with ARDS(P<0. 05). Western blotting analysis showed that p-RhoA level was significantly increased in HUVECs treated with the serum of HF+HP-treated SAP patients with ARDS (P<0. 05), and the total RhoA protein expressions were not significantly different among different groups (P > 0. 05). Immunofluorescence indicated that p-RhoA was largely distributed in the cytoplasm of HUVECs, and the changes were consistent with the data from Western blotting analysis. Conclusion SAP patientswith ALI/ARDS have high circulation TNF-α. Treatment with HF+HP can effectively remove the excessive TNF-α in the blood of SAP patients with ALI/ARDS and inhibit activation of RhoA, subsequently decreasing the high permeability of endothelial cells.
